Robert N. Fried - Apr 9, 2025 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Role
Chief Executive Officer, Director
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Stock symbol
NAGE
Transactions as of
Apr 9, 2025
Transactions value $
$220,001
Form type
4
Date filed
4/9/2025, 07:52 PM
Previous filing
Feb 27, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAGE Common Stock Options Exercise $220K +66.7K +6.86% $3.30 1.04M Apr 9, 2025 Direct F1
holding NAGE Common Stock 95K Apr 9, 2025 By Fried-Travis Revocable Trust U/A Dated 06/02/1999
holding NAGE Common Stock 250K Apr 9, 2025 By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020 F2
holding NAGE Common Stock 250K Apr 9, 2025 By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020 F2
holding NAGE Common Stock 12.7K Apr 9, 2025 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAGE Stock Options (right to buy) Options Exercise $0 -66.7K -100% $0.00 0 Apr 9, 2025 Common Stock 66.7K $3.30 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration on July 29, 2025, paying the exercise price with cash, and has not sold any of the shares received upon exercise.
F2 The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3 6,745 shares of Common Stock held by Jeremy Fried and 6,001 shares of Common Stock held by Benjamin Fried, who are sons of Robert Fried.